Vanda Pharmaceuticals, Inc. (VNDA)

Last Three Months

20-Jan-24 -- 19-Apr-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Reduce

Insider Trading Sentiment: Sell

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

35

0

5

+1

0

+2

0

+3

Two Year Chart

20-Apr-22 -- 19-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
06-Mar-24 4:46 PM View:	05-Mar-24 Sale ($35.88K)	Birznieks Gunther SVP, Business Development		Vanda Pharmaceuticals, Inc. - VNDA	52% 205.98K to 313.57K	0	0	--	--	Show Txns Hide Txns

06-Mar-24 4:50 PM View:	05-Mar-24 Sale ($37.40K)	Williams Timothy SVP & General Counsel		Vanda Pharmaceuticals, Inc. - VNDA	121% 88.91K to 196.82K	0	0	--	--	Show Txns Hide Txns

06-Mar-24 4:48 PM View:	05-Mar-24 Sale ($38.83K)	Wijkstrom Joakim SVP, Chief Marketing Officer		Vanda Pharmaceuticals, Inc. - VNDA	14% 113.82K to 129.79K	0	0	--	--	Show Txns Hide Txns

06-Mar-24 4:46 PM View:	05-Mar-24 Sale ($37.41K)	Moran Kevin Patrick SVP, CFO & Treasurer		Vanda Pharmaceuticals, Inc. - VNDA	91% 121.35K to 231.65K	0	0	--	--	Show Txns Hide Txns

06-Mar-24 4:47 PM View:	05-Mar-24 Sale ($100.27K)	Polymeropoulos Mihael Hristos President and CEO Director		Vanda Pharmaceuticals, Inc. - VNDA	27% 1.48M to 1.87M	0	0	--	--	Show Txns Hide Txns